(1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity

   
   

Compounds of the formula ##STR1## where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects of reducing serum thyroxine levels and transiently increasing triglyceride levels.

Les composés du ## du ## STR1 de formule où les variables ont la signification définie dans les spécifications sont capables de réduire des niveaux de glucose de sérum dans les mammifères diabétiques sans effets secondaires indésirables de réduire des niveaux de thyroxine de sérum et d'augmenter transitoirement des niveaux de triglycéride.

 
Web www.patentalert.com

< Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated

< Compounds having activity as inhibitors of cytochrome P450RAI

> Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists

> Preparation of topical regional compositions for the relief of pain

~ 00112